Proposed issue of securities - PER
Released
Released
Announcement PDF
Appendix 3B - Proposed issue of securities
Announcement Summary
Entity name
PERCHERON THERAPEUTICS LIMITED
Announcement Type
New announcement
Date of this announcement
7/5/2025
The Proposed issue is:
A bonus issue
Total number of +securities proposed to be issued for a bonus issue
ASX +security code
+Security description
New class-code to be
confirmed
Unquoted options exercisable at $0.035 per option on or
before 20 May 28
Maximum Number of
+securities to be issued
108,743,763
Ex date
12/5/2025
+Record date
13/5/2025
+Issue date
20/5/2025
Refer to next page for full details of the announcement
Appendix 3B - Proposed issue of securities
1/5
Appendix 3B - Proposed issue of securities
Part 1 - Entity and announcement details
1.1 Name of +Entity
PERCHERON THERAPEUTICS LIMITED
We (the entity named above) give ASX the following information about a proposed issue of +securities and, if ASX agrees
to +quote any of the +securities (including any rights) on a +deferred settlement basis, we agree to the matters set out in
Appendix 3B of the ASX Listing Rules.
If the +securities are being offered under a +disclosure document or +PDS and are intended to be quoted on ASX, we also
apply for quotation of all of the +securities that may be issued under the +disclosure document or +PDS on the terms set
out in Appendix 2A of the ASX Listing Rules (on the understanding that once the final number of +securities issued under
the +disclosure document or +PDS is known, in accordance with Listing Rule 3.10.3C, we will complete and lodge with ASX
an Appendix 2A online form notifying ASX of their issue and applying for their quotation).
1.2 Registered Number Type
Registration Number
ABN
41095060745
1.3 ASX issuer code
PER
1.4 The announcement is
New announcement
1.5 Date of this announcement
7/5/2025
1.6 The Proposed issue is:
A +bonus issue
Appendix 3B - Proposed issue of securities
2/5
Appendix 3B - Proposed issue of securities
Part 2 - Details of proposed bonus issue
Part 2A - Conditions
2A.1 Do any external approvals need to be obtained or other conditions satisfied before the +bonus issue can
proceed on an unconditional basis?
No
Part 2B - Issue details
+Class or classes of +securities that will participate in the proposed issue and +class or classes of +securities
proposed to be issued
ASX +security code and description
PER : ORDINARY FULLY PAID
Is the proposed security a 'New
class' (+securities in a class that is
not yet quoted or recorded by ASX)
or an 'Existing class' (additional
securities in a class that is already
quoted or recorded by ASX)?
New class
Will the proposed issue of this
+security include an offer of
attaching +securities?
No
If the entity has quoted company
options, do the terms entitle option
holders to participate on exercise?
No
Details of +securities proposed to be issued
ISIN Code (if Issuer is a foreign company and +securities do not have +CDIs
issued over them)
Have you received confirmation from
ASX that the terms of the proposed
+securities are appropriate and
equitable under listing rule 6.1?
Yes
Will the entity be seeking quotation
of the 'new' class of +securities on
ASX?
No
ASX +security code
+Security description
New class-code to be confirmed
Unquoted options exercisable at $0.035 per option on or before 20 May 28
+Security type
Options
Issue ratio (ratio to existing holdings at which the proposed +securities will be issued)
The quantity of additional +securities For a given quantity of +securities
to be issued
held
1
What will be done with fractional
Appendix 3B - Proposed issue of securities
10
Maximum number of +securities
proposed to be issued (subject to
3/5
Appendix 3B - Proposed issue of securities
What will be done with fractional
entitlements?
proposed to be issued (subject to
rounding)
108,743,763
Fractions rounded down to the nearest
whole number or fractions disregarded
Will all the +securities issued in this class rank equally in all respects from
their issue date?
Yes
Options details
+Security currency
Exercise price
Expiry date
AUD - Australian Dollar
AUD 0.0350
20/5/2028
Details of the type of +security that will be issued if the option is exercised
PER : ORDINARY FULLY PAID
Number of securities that will be issued if the option is exercised
1 ordinary fully paid share in Percheron Therapeutics Limited (ASX PER)
Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities
proposed to be issued or provide the information by separate announcement.
Please see link to Prospectus lodged with the ASX on 7 May 2025 https://www.asx.com.au/markets/trade-our-cash-marke
t/announcements.per
Part 2C - Timetable
2C.1 +Record date
13/5/2025
2C.3 Ex date
12/5/2025
2C.4 Record date
13/5/2025
2C.5 +Issue date
20/5/2025
2C.6 Date trading starts on a normal T+2 basis
2C.7 First settlement of trades conducted on a +deferred settlement basis and on a normal T+2 basis
Appendix 3B - Proposed issue of securities
4/5
Appendix 3B - Proposed issue of securities
Part 2D - Further Information
2D.1 Will holdings on different registers or subregisters be aggregated for the purposes of determining
entitlements to the +bonus issue?
No
2D.2 Countries in which the entity has +security holders who will not be eligible to participate in the proposed
+bonus issue
United States, United Arab Emirates, United Kingdom, China and Norway
2D.3 Will the entity be changing its dividend/distribution policy as a result of the proposed +bonus issue
No
2D.4 Details of any material fees or costs to be incurred by the entity in connection with the proposed +bonus
issue
A breakdown of expected fees can be found at Section 5.10 of the prospectus lodged on 7 May 2025 https://www.asx.co
m.au/markets/trade-our-cash-market/announcements.per
2D.5 Any other information the entity wishes to provide about the proposed +bonus issue
Appendix 3B - Proposed issue of securities
5/5
Share your feedback
Discover